We demonstrate that overexpression of Nogo‐B in HCC cells or recombinant Nogo‐B significantly promotes tumor angiogenesis, while inhibition of Nogo‐B via shRNA or neutralizing antibody impedes angiogenesis in vitro and in vivo. Here, RTN4 is linked to hepatocellular carcinoma.